Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty ...
(Reuters) - Kenvue reported third-quarter sales marginally below Wall Street estimates on Thursday, hurt by weakness in its ...
Kenvue reported third-quarter sales slightly below Wall Street expectations on Thursday, hurt by weak sales of its skin ...
Net income: US$383.0m (down 13% from 3Q 2023). Profit margin: 9.8% (down from 11% in 3Q 2023). EPS: US$0.20 (down from ...
Headlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in ...
Kenvue owns a strong portfolio of household brands like Tylenol, Benadryl and Band-Aid. Read why I continue to rate KVUE ...
The longtime beauty executive has been named president of skin health and beauty in North America, Europe, Middle East and ...
6d
Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in ...
Kenvue announced financial results for the fiscal third quarter which ended September 29, 2024. Net sales in Q3 reached ...
The Neutrogena owner has named former Hydrafacial and Coty exec Stanleick as President, Skin Health & Beauty for North ...
Jefferies has recently initiated Kenvue Inc (KVUE) stock to Buy rating, as announced on September 24, 2024, according to Finviz. Earlier, on September 24, 2024, RBC Capital Mkts had reduced the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback